Table 1.
Classification | Gene | KO/CKO/Tg/knock-in | Phenotype | References |
---|---|---|---|---|
TGF-β ligands | Tgfb1 | KO | Early death (1 month) | 88 |
Tgfb1−/−Rag2−/− | Reduced bone density; OB↓ | 152 | ||
Col1α1 Prom-Tgfb1 H222D Tg (1) | Diaphyseal thickening, fluctuating bone volume, increased bone remodeling, prone to fracture; OB↑; OC↑ | 152 | ||
Col1α1 Prom-Tgfb1 H222D Tg | Knee and temporomandibular joint osteoarthritis↑ | 221,222 | ||
Tgfb2 | KO | Perinatal mortality; neural arch defect; bifurcated sternum; shortened radius and ulna | 85 | |
Tgfb3 | KO | Die within 20 h of birth; failure of the palatal shelves to fuse leading to cleft palate | 86,87 | |
BMP ligands | Bmp2 | Col2α1-CreER | Severe chondrodysplasia; shortened stature and limbs; chondrocyte proliferation↓ & hypertrophy↓ | 50 |
Prx1-Cre | Normal limb patterning | 51 | ||
Bmp7 | KO | Die at birth; skull base defects; rib & sternum malformation; hindlimb polydactyly | 326 | |
Bmp7, Alk6 | DKO | Malformed and shortened appendicular bones compared to Bmp7−/− | 25 | |
Bmp2, 7 | Prx1-Cre;Bmp2f/f;Bmp7−/− | Slightly diminished appendicular skeleton; missing the last phalanx in digit III; malformed fibulae | 51 | |
Bmp4 | Col2α1-CreER | Mild chondrodysplasia | 50 | |
Prx1-Cre | Polydactyly | 51,52 | ||
Bmp2, 4 | Col2α1-CreER | Severe chondrodysplasia; severely shortened and malformed or missing long bone skeleton element & fused joints; chondrocyte proliferation↓ & hypertrophy↓ | 50 | |
Prx1-Cre | Polydactyly; complete syndactyly; delayed mineralization; chondrogenesis ↓ ; osteogenesis↓ | 51 | ||
BMP3/GDF10 | Col1 Prom-Bmp3 Tg | Late hypertrophic chondrocyte differentiation↓; thinner cortical bone; mineralization ↓ ; rib fracture | 115 | |
KO | Increased bone density | 28 | ||
Bmp14/GDF5 | bpJ (2) | Normal axial bones; shortened limbs and digits; missing joints of autopods; missing phalange elements | 25,327 | |
No delay in fracture healing | 328 | |||
Increased joint damage in collagen-induced arthritis; reduced bone density | 329 | |||
GDF5, Alk6 | bpJ/bpJ;Alk6−/− | Same as bpJ | 25 | |
Type I receptors | Alk2/Acvr1 | Col2α1-Cre | Shortened cranial base; hypoplastic cervical vertebrae | 49 |
Osx-Cre | Mandibular bone density ↓ ; OB ↓ ; sRANKL ↑ ; OC↑ | 113 | ||
Q207D Tg | Fibrodysplasia ossificans progressive | 127,130,132 | ||
Acvr1tnR206H/+;Tie2-Cre | Fibrodysplasia ossificans progressive | 128 | ||
R206H knock-in | Fibrodysplasia ossificans progressive | 129 | ||
Alk3/Bmpr1A | Col2α1-Cre | Split dorsal arches; shortened limbs; hypoplastic scapula; chondrodysplasia, chondrocyte proliferation ↓ , hypertrophy ↓ , terminal differentiation ↓ , and apoptosis↑ | 48,49,65 | |
Gdf5-Cre | Automatically develop osteoarthritis | 330 | ||
Col1α1-CreER | bone mass in long bones and ribs ↑ ; strength ↑ ; OC↓ | 148,149 | ||
Sp7-Cre | Trabecular bone mass↑ | 147 | ||
Dmp-Cre | Trabecular bone mass↑ (13-fold); OB proliferation↑ and activity ↓ ; RANKL & SOST ↓ ; OC↓ | 147,176 | ||
Alk6/Bmpr1B | KO | Brachypodism; reduced phalangeal elements; the fusion of appendicular joints, similar to GDF5 mutant (bpJ) mice | 25,48,49,65 | |
KO | Transient and gender-specific osteopenia caused by reduced osteogenesis from MSCs | 331 | ||
Col1α1 Prom-truncated Alk6 Tg | Reduced BMD and bone volume; reduced osteoblast and osteoclast number | 332 | ||
Alk3, Alk6 | Col2α1-Cre;Alk3f/f;Alk6+/− | Phenotype resembling and more severe than Alk3 CKO mice | 48,65 | |
Col2-Cre;Alk3f/f;Alk6−/− | Severe defects in cartilage formation and skeletogenesis | 48 | ||
Alk2, Alk3 | Col2-Cre | Malformed axis skeleton (vertebra, cervical and thoracic regions); more severe appendicular defects than Alk3 CKO mice | 49 | |
Alk2, Alk6 | Col2-Cre;Alk2f/f;Alk6−/− | More severe axis and appendicular defects than each single KO | 49 | |
Alk5/TGFBR1 | Dermo-Cre | Short and wide long bones, ectopic cartilaginous protrusions, reduced bone volumes | 83 | |
Col2α1 Prom-Alk5 DN Tg | Elongated limbs; chondrocyte proliferation↑ | 68 | ||
Col2α1-CreERT | Automatic osteoarthritis | 208,333 | ||
Type II receptors | Tgfbr2 | Nestin-CreER | Knee osteoarthritis↓ | 221 |
ColX-Cre | Delayed chondrocyte terminal differentiation; impeded mineralization | 84 | ||
Prx-Cre | Die at birth; reduced periodontal and frontal bone; shortened limbs; split sternum; autopod joint fusion; reduced mineralization; chondrocyte proliferation↓ & hypertrophy↑ | 78,81 | ||
Col2α1-Cre | Survive; neural arch defect; missing/incomplete intervetebral discs; progressive reduction in long bone length | 79,80 | ||
Sp7-Cre (Dox) | Early death (1 M); reduced body size; reduced bone volume; increased bone marrow adipose tissue; disrupted molar tooth formation; OB↓ | 157,334 | ||
Ocn-Cre | bone density ↑ ; OB ↑ ; OC↑ | 172 | ||
Bmpr2 | Prx1-Cre | Trabecular bone volume ↑ ; BFR ↑ ; selectively abolish Activin-Smad2/3 but not Bmp-Smad1/5/8 signaling | 335 | |
Col1α1 Prom-Bmpr2 DN Tg | Dwarfism; delayed mineralization; bone volume ↓ ; no change in cortical bone | 114 | ||
ActRIIA/Acvr2A | Ocn-Cre | Trabecular bone volume↑ | 336 | |
ActRIIB/Acvr2B | KO | Late hypertrophic chondrocyte differentiation ↓ ; thinner cortical bone; mineralization ↓ ; rib fracture | 115 | |
Ocn-Cre | Normal | 336 | ||
ActRIIA, ActRIIB | Ocn-Cre | Trabecular bone volume↑ like ActRIIA−/− | 336 | |
Canonical pathway | Smad1 | Col1α1-Cre | Osteopenia; OB proliferation and differentiation↓ | 337 |
Col2α1-Cre | Shortened growth plate; chondrocyte hypertrophy↓ and proliferation↓ | 68 | ||
Smad1/5 | Col2α1-Cre;Smad1f/f;Smad5+/− | Similar and more severe phenotype than Smad1 CKO | 68 | |
Smad1/5 | Col2α1-Cre | Chondrodysplasia; shortened limbs; thicker perichondrium; matrix production ↓ ; hypertrophy↓ | 69 | |
Smad8 | KO | Normal | 69 | |
Smad1/5/8 | Col2α1-Cre;Smad1f/f;Smad5f/f;Smad8−/− | Absence of an axial skeleton; severely disorganized appendicular bones | 69 | |
Smad2 | Col2α1-Cre | Similar and more severe phenotype than Smad3 KO mice | 89 | |
Smad2/3 | Col2α1-Cre;Smad2f/f;Smad3−/− | Similar and more severe phenotype than Smad3 KO mice | 89 | |
Smad3 | KO | Postnatal dwarfism; expanded columnar and hypertrophic zone; chondrocyte proliferation↑ and hypertrophy↑ | 89 | |
KO | Knee and temporomandibular joint osteoarthritis | 214,215 | ||
KO | Osteopenia; OB and OCY apoptosis↑ | 156 | ||
Smad4 | Tbx18-Cre | Short limbs, chondrogenesis↓ & hypertrophy ↓ , missing stylopod | 40 | |
Sp7-Cre (Dox) | Increased trabecular bone mass | 147 | ||
Sp7-Cre | Stunted growth; spontaneous fractures; increased trabecular bone volume; decreased BMD; a combination of features seen in osteogenesis imperfecta, cleidocranial dysplasia, and Wnt-deficiency syndromes | 118 | ||
Dmp-Cre | Increased trabecular bone mass (~2-fold) | 147 | ||
Col1α1-Cre | Increased trabecular bone mass; protection from tail suspension-induced bone loss; OB & OCY number ↑ ; OB & OCY apoptosis↓ | 178 | ||
Ocn-Cre | Lower bone mass < 6-month, more bone mass > 7-month | 177 | ||
Ctsk-Cre | Reduced bone mass; OC↑ | 186 | ||
Non-canonical pathway | TAK1 | Col2α1-CreER | Growth retardation; osteoarthritis markers ↑ ; no osteoarthritis histological signs | 71 |
Osx-Cre | Cleidocranial dysplasia (CCD)-like phenotype (clavicular hypoplasia and delayed fontanelle fusion); OB ↓ ; reduced cancellous and trabecular bone volume | 116 | ||
Col2α1-Cre | Shorter limbs; chondrocyte proliferation ↓ , survival↓ & hypertrophy ↓ ; failure to maintain interzone cells of the elbow joint | 338 | ||
Prx1-Cre | Widespread joint fusions; chondrocyte hypertrophy and proliferation | 338 | ||
p38 | Ocn-Cre | OB activity and BFR ↓ ; reduced cancellous and trabecular bone volume | 117 | |
Col2α1 Prom-p38DN Tg | Shortened limbs; knee joint osteoarthritis↑ | 210 | ||
p38b−/− | A substantial decrease in long bone mineralization and a more modest effect on the calvarium | 116 | ||
MKKs | Mkk3−/−Mkk6+/− and Mkk3−/− | Similar phenotype to Tak1f/f;Osx-Cre mice | 116 | |
I-SMAD and ubiquitin-related regulation | Smad6 | Col11α1 Prom-Smad6 Tg | Dwarfism and osteopenia; chondrocyte hypertrophy↓ | 279 |
KO | Dwarfism; defects in axial and appendicular bones; delayed onset of hypertrophy | 280 | ||
Smad6;Smurf1 | Col11α1::Tg | More severely delayed endochondral ossification than Smad6 Tg | 279 | |
Smad7 | ΔExon1 | Osteopenia; BFR ↓ ; OC↑ | 282 | |
KO | Chondrocyte proliferation and hypertrophy ↓ ; shortened growth plate | 339 | ||
Prx1 Prom-Tg; Col11 Enh-Tg; Col11 Prom-Tg | Chondrodysplasia; mesenchymal condensation ↓ ; chondrocyte proliferation and hypertrophy↓ | 283 | ||
Smurf1 | KO | Bone mass ↑ ; BFR↑ | 286 | |
Col1α1 Prom-Tg | Osteopenia; BFR↓ | 285 | ||
Smurf2 | Col2α1 Prom-Tg | Osteoarthritis; intervertebral disc degeneration | 291,292 | |
KO | Protection from age-related and DMM-induced osteoarthritis | 293 | ||
KO | Osteopenia ↓ ; OC↑ | 296 | ||
KO | Enhanced BMP-induced ectopic bone formation | 294 | ||
PLEKHO1 | Osterix-Cre | Protection from age-related bone loss | 289 | |
Osterix Prom-Tg | Age-related bone loss | 289 | ||
NEDD4 | Col1α1-Cre | Bone mass ↓ ; OB↓ | 298 | |
Col1α1 Prom-Tg | Bone mass ↑ ; OB↑ | 298 | ||
Jab1 | Osx-Cre | Dwarfism; trabecular bone mass↓ | 303 | |
Antagonists | Noggin | Ocn Prom-Tg | Osteopenia; BFR↓ | 250,253 |
Ocn-Cre | Osteopenia | 254 | ||
KO | Hyperplasia of cartilage; joint development failure; multiple skeletal defects related to neural tube and somite patterning (failure of neural tube closure, broad club-shaped limbs, loss of caudal vertebrae, a shortened body axis, and retention of a small vestigial tail) | 66,67 | ||
Grem1 | Ocn-Cre | Bone mass ↑ ; BFR↑ | 258 | |
Ocn Prom-Tg | Bone fractures; bone mass ↓ ; BFR↓ | 259 | ||
FS | Tg | Bone mass ↓ ; bone fractures | 262 | |
Co-receptors | β-glycan | KO | Defective palate development with OB↓ | 267 |
Nrps | KO | Bone mass ↓ ; OB ↓ ; OC↓ | 268 | |
Neogenin | KO | Elongated growth plate; chondrocyte proliferation & apoptosis ↓ ; endochondral ossification↓ | 276 | |
Other regulators | Tmem53 | KO | Sclerosing bone | 308 |
Endofin | Col1 Prom-Endofin F872A Tg | Bone mass ↑ ; BFR↑ | 304 |
Prom promoter, Enh Enhancer, Tg transgenic, KO knockout, CKO conditional knockout, BFR bone formation rate, OB osteoblast, OC osteoclast, OCY osteocyte, BMD bone mineral density, DN dominant negative
Annotations.
(1) Col1α1 Prom-Tgfb1 H222D Tg, transgenic mice carrying a Tgfb1 H222D mutant under the control of Col1α1 promoter; Tgfb1 H222D mutant is found in human Camurati-Engelmann disease (CED). This mouse model is also named as Tgfb1-CED or CED mice.
(2) BpJ is the mouse model carrying Gdf5 mutation (bp-J allele) which occurs spontaneously in the A/J strain. Bp is short for brachypodism.